Identification of a new non-functional CYP2C18 allele in Japanese: Substitution of T204 to A in exon2 generates a premature stop codon

Pharmacogenetics

Volumn 6, Issue 1, 1996, Pages 117-119

  Komai, Koichiro ^a   Sumida, Kayo ^a   Kaneko, Hideo ^a   Nakatsuka, Iwao ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

CYP2C18; metabolism; P450; polymorphism

Indexed keywords

CYTOCHROME P450 ISOENZYME; DNA;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG METABOLISM; EXON; GENETIC POLYMORPHISM; HUMAN; JAPAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; AMINO ACID SEQUENCE; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CODON, TERMINATOR; CYTOCHROME P-450 ENZYME SYSTEM; DNA; EXONS; HUMANS; JAPAN; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0029868939     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199602000-00011     Document Type: Article

References (10)

1. de Morais SMF, Schweikl H, Goldstein JA. Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. Biochem Biophys Res Comm 1993: 194(1), 194-201.
2. de Morais SMF, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic polymorphism of S-mephenytoin. Metabolism in humans. J Biol Chem 1994(a): 269(22), 15419-15422.
3. de Morais SMF, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Molec Pharmacol 1994(b): 46, 594-598.
4. Furuya H, Mayer UA, Gelboin HV, Gonzalez FJ. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA. Molec Pharmacol 1991: 40, 375-382.
5. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 1994: 33, 1743-1752.
6. Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 1991: 30, 3247-3255.
7. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994: 270(1), 414-423.
8. Wilkinson GR, Guengerich FP, Branch RA. Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther 1989: 43, 53-76.
9. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992: 22, 1-21.
10. Wrighton SA, Stevens JC, Becker GW, VandenBranden M. Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Archiv Biochem Biophys 1993: 306, 240-245.